UK markets open in 2 hours 45 minutes

Immunocore Holdings plc (IMCR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
61.91+1.68 (+2.79%)
At close: 04:00PM EDT
61.91 0.00 (0.00%)
After hours: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-55,287
-55,287
-52,543
-180,029
-74,093
Depreciation & amortisation
4,090
4,090
5,335
7,591
8,976
Deferred income taxes
-
-
-2,921
-9,405
-13,267
Stock-based compensation
32,469
32,469
32,888
48,894
8,162
Change in working capital
5,782
5,782
-24,165
-21,959
-28,844
Accounts receivable
-17,871
-17,871
-26,264
-4,863
-
Accounts payable
2,625
2,625
4,913
1,474
-
Other working capital
-2,485
-2,485
-51,412
-144,492
-64,324
Other non-cash items
2,059
2,059
2,072
2,298
-1,696
Net cash provided by operating activities
2,940
2,940
-49,209
-143,106
-61,250
Cash flows from investing activities
Investments in property, plant and equipment
-5,425
-5,425
-2,203
-1,386
-3,074
Other investing activities
-
-
2,385
15
3,164
Net cash used for investing activities
-5,425
-5,425
-2,197
-1,280
1,143
Cash flows from financing activities
Debt repayment
0
0
-50,000
0
-4,426
Common stock issued
0
0
139,515
286,887
83,218
Dividends paid
-
-
0
0
0
Other financing activities
-
-
-3,769
-15,543
-176
Net cash used provided by (used for) financing activities
34,346
34,346
145,442
288,185
115,941
Net change in cash
31,861
31,861
94,036
143,799
55,834
Cash at beginning of period
402,472
402,472
321,082
176,658
73,966
Cash at end of period
442,626
442,626
402,472
321,082
129,716
Free cash flow
Operating cash flow
2,940
2,940
-49,209
-143,106
-61,250
Capital expenditure
-5,425
-5,425
-2,203
-1,386
-3,074
Free cash flow
-2,485
-2,485
-51,412
-144,492
-64,324